ArticleThe Biochemical journal2026
Construction and regulation of microbial cell factories for enhancing the biosynthesis of O-acetyl-l-homoserine in Escherichia coli W3110.
Article in The Biochemical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
O-Acetyl-l-homoserine (OAH) is a versatile platform compound with extensive potential applications. It is a key precursor for the synthesis of l-methionine and S-adenosylmethionine. Currently, the microbial fermentation process for the production of OAH still faces challenges, such as low fermentation yield and long fermentation period. In this study, the supply of key precursors, including l-aspartic acid, l-homoserine, and acetyl-CoA, was firstly enhanced, which increased the OAH production from 7.25 g/l to 12.95 g/l in shaking flask fermentation. Subsequently, the non-oxidative glycolysis pathway (NOG pathway) was constructed and optimized to minimize the carbon loss and improve the carbon sources utilization, resulting in an increase in OAH production to 15.59 g/l. Finally, by accelerating cell division and enhancing the glucose transport system, OAH production was further improved to 17.23 g/l. The OAH production of the engineered strain OAH23 achieved a production level of 66.25 g/l in a 5 l bioreactor for 68 h, with the yield of 0.41 g/g glucose. The metabolic regulation strategy outlined in this study offers valuable insights for the efficient biosynthesis of OAH and other acetylated amino acids in E. coli.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.